कृपया अन्य खोज का प्रयास करें
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Hisashi Ietsugu | 74 | 1986 | Chairman of the Managing Board & Group CEO |
Kaoru Asano | 65 | 2013 | President & Representative Director |
Kenji Tachibana | 66 | 2013 | Sr. MD of Corp Mgmt & Regulatory Affairs, Sr. Exec. Officer & Member of the Managing Board |
Kazumasa Hashimoto | 70 | 2020 | Independent Outside Member of the Managing Board |
Michihide Iwasa | 67 | 2020 | Independent Outside Member of Managing Board |
Masayo Takahashi | 62 | 2016 | Independent Outside Member of the Managing Board |
Kazuo Ota | 68 | 2019 | Independent Outside Member of the Managing Board |
Tomoo Aramaki | 57 | 2022 | Member of the Managing Board |
Hidekazu Fukumoto | 68 | 2021 | Independent Outside Member of the Managing Board |
Iwane Matsui | 62 | 2017 | Senior Managing Executive Officer & Member of the Managing Board |
Tomokazu Yoshida | 59 | 2017 | Managing Executive Officer, CTO & Member of the Managing Board |
Takashi Ono | 58 | 2019 | Member of the Managing Board, Senior Executive Officer & MD |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है